Immediate Impact
12 by Nobel laureates 4 from Science/Nature 70 standout
Citing Papers
Nanomedicine Tumor Targeting
2024 Standout
Electrochemical Late-Stage Functionalization
2023 Standout
Works of Jamie Ketas being referenced
Phase I/II Trial of Epratuzumab (Humanized Anti-CD22 Antibody) in Indolent Non-Hodgkin’s Lymphoma
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Jamie Ketas | 371 | 204 | 289 | 244 | 7 | 584 | |
| Wendy J.M. Mackus | 360 | 311 | 345 | 212 | 8 | 740 | |
| Michaela Feuring Buske | 527 | 314 | 194 | 339 | 5 | 715 | |
| C. Jonas | 504 | 262 | 158 | 350 | 9 | 709 | |
| AC Aisenberg | 386 | 299 | 86 | 171 | 13 | 623 | |
| Andreas Braeuninger | 348 | 231 | 101 | 206 | 10 | 625 | |
| Viktoria Hjalmar | 338 | 324 | 107 | 122 | 13 | 530 | |
| Amy Goodrich | 392 | 378 | 113 | 149 | 14 | 548 | |
| TW Mak | 290 | 198 | 70 | 197 | 13 | 668 | |
| Annette Hänel | 455 | 225 | 108 | 303 | 13 | 628 | |
| Nikolaos Touroutoglou | 152 | 100 | 117 | 303 | 8 | 549 |
All Works
Loading papers...